Completion of a Phase I clinical trial has demonstrated the great promise of a completely new type of cancer treatment, according to results announced this June in The New England Journal of Medicine by scientists at the Institute of Cancer Research (ICR) and the Royal Marsden Hospital in the United Kingdom, working with pharma firm AstraZeneca.
There is a profound difference between the complexity of cosmetic surgery or organ transplant procedures, for example, and other operations. Whilst procedures such as hair transplants or eyelid surgery present an alteration to the owner's body composition and changes to the patient's outlook, those changes were desired and planned for, in the hope that something marvellous will result and so…
An interdisciplinary team of researchers at Brigham and Women's Hospital (BWH) and the Harvard-MIT Division of Health Sciences and Technology has demonstrated a better way to deliver cancer drugs directly to tumors by using specially engineered nanoparticles that can inhibit a signaling pathway and deliver a higher concentration of medication to the specific area.
17-21 March Stockholm Sweden
Working in partnership to integrate diagnostic imaging, laboratory diagnostics and IT, the Hospital Clinic Barcelona and Siemens Healthcare aim to develop innovative systems to prevent, treat and follow-up for various pathologies.
Olwen Glynn Owen reports on MammaPrint, a test that pinpoints the risk of breast cancer recurrence from the primary tumour's genetic make-up. Women with breast cancer tumours under
Tumour ablation - and Radiofrequency (RF) ablation in particular - is getting more and more important in oncology. The therapy option offers benefits in terms of costs, ease of set-up and flexibility so that experts see the need to expand the applications of it.
Two thirds of cancer patients receive little or no information about the survival benefits of having palliative chemotherapy before making a decision about treatment, according to a study published on the British Medical Journal website.
Women who survive breast cancer for at least five years have a 89% chance that it will not recure. But those, who are still suffering and on endocrine treatment are likely to get arthralgia and arthritis.
Limited public and political awareness of colorectal cancer (CRC), few formal screenings programms, delayed access to treatment - the first cross-country report on the management and funding of colorectal cancer (CRC) reveals an urgent need for action to improve the survival of patients in Europe and Australia.
The next big development in biological targeted therapies for advanced breast cancer will be drugs acting via multiple mechanisms, experts told delegates attending the 1st Asian Breast Cancer conference, held in New Delhi 9-10 February.
Along with paediatric radiology, interventional radiology will have a high profile at the 89th German Radiology Congress and 5th Joint Congress with the Austrian Radiology Society. Congress presidents Professor Dierk Vorwerk and Professor Richard Fotter outlined what's on the agenda for the expected 6,900 visitors. Training, they pointed out, will aim at those preparing to specialise in…
'How do you treat the HIV-positive, diabetic, schizophrenic patient presenting with chest pain? By making the necessary information available for personalised medicine'
As part of a research and development project, doctors at the University Hospital Magdeburg, Germany, are treating oncology patients with local minimally invasive surgery (MIS) which, for the first time, can be carried out under radiological image control using high-field magnetic resonance imaging (MRI). The system offers excellent image quality under extremely favourable, radiation-free…
For women (or friends and relatives of women with breast cancer),
Professor Loennidis, University of Ioannina School of Medicine, Greece, and a team of researchers examined 242 randomized trials, performed during the last fourty years and covering the efficiacy of chemotherapy treatment for advanced stages of colorectal cancer. The scientist compared the benefits and outcome of different systemic treatment regimes.
Besides sophisticated imaging technologies, biomarkers are the key to molecular medicine. Therefore, the development of new and more specific biomarkers is the primary aim of researchers around the world and - since this June - it is also the aim of the new founded European Institute of Molecular Imaging, a cooperation project of the University Münster, Germany and Siemens Medical Solutions.…
The new Olympus E-330 micro-imaging system for microscopy includes the world's first digital SLR camera to show real-time frame images on the LCD, the company reports. `The system is based around a 7.5 Megapixel sensor, which together with an array of unique features delivers incredibly sharp and vibrant images directly onto a 2.5 inch high-resolution colour LCD. Other features of the micro…
Prostate cancer, the most common neoplasm in men, often progresses from an androgen-dependant state (and is commonly treated by androgen ablation therapies) to a hormone-refractory stage, therefore making hormone therapy ineffective. The response duration to androgen ablation therapy is finite and ultimately most prostate cancer will become hormone-insensitive.
Chemotherapy is used against various cancers and is often consideres as a last resort – especially if the cancer has metastasised. Since chemotherapy agents can cause severe side effects, research aims to make treatment more tolerable. Keep up-to-date with the latest research news, medical applications, and background information.